1. Home
  2. SLM vs GRFS Comparison

SLM vs GRFS Comparison

Compare SLM & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLM
  • GRFS
  • Stock Information
  • Founded
  • SLM 1972
  • GRFS 1940
  • Country
  • SLM United States
  • GRFS Spain
  • Employees
  • SLM 1710
  • GRFS N/A
  • Industry
  • SLM Finance: Consumer Services
  • GRFS Biotechnology: Pharmaceutical Preparations
  • Sector
  • SLM Finance
  • GRFS Health Care
  • Exchange
  • SLM Nasdaq
  • GRFS Nasdaq
  • Market Cap
  • SLM 5.9B
  • GRFS 7.2B
  • IPO Year
  • SLM N/A
  • GRFS 2006
  • Fundamental
  • Price
  • SLM $27.86
  • GRFS $9.63
  • Analyst Decision
  • SLM Buy
  • GRFS Hold
  • Analyst Count
  • SLM 11
  • GRFS 1
  • Target Price
  • SLM $34.18
  • GRFS $10.30
  • AVG Volume (30 Days)
  • SLM 2.1M
  • GRFS 489.5K
  • Earning Date
  • SLM 10-22-2025
  • GRFS 01-01-0001
  • Dividend Yield
  • SLM 1.87%
  • GRFS 1.47%
  • EPS Growth
  • SLM N/A
  • GRFS 132.60
  • EPS
  • SLM 1.97
  • GRFS 0.53
  • Revenue
  • SLM $1,206,861,000.00
  • GRFS $8,744,226,659.00
  • Revenue This Year
  • SLM $6.70
  • GRFS $6.00
  • Revenue Next Year
  • SLM $14.31
  • GRFS $6.71
  • P/E Ratio
  • SLM $14.15
  • GRFS $24.37
  • Revenue Growth
  • SLM N/A
  • GRFS 9.32
  • 52 Week Low
  • SLM $21.10
  • GRFS $6.19
  • 52 Week High
  • SLM $34.97
  • GRFS $11.14
  • Technical
  • Relative Strength Index (RSI)
  • SLM 28.66
  • GRFS 40.71
  • Support Level
  • SLM $28.67
  • GRFS $9.79
  • Resistance Level
  • SLM $29.17
  • GRFS $10.14
  • Average True Range (ATR)
  • SLM 0.85
  • GRFS 0.18
  • MACD
  • SLM -0.32
  • GRFS -0.03
  • Stochastic Oscillator
  • SLM 2.21
  • GRFS 9.23

About SLM SLM Corporation

SLM Corp is an education solutions company. It business is to originate and service loans to students and their families to finance the cost of their education. The provide Private Education Loans to mean education loans to students or their families that are not made, insured, or guaranteed by any state or federal government.

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

Share on Social Networks: